Meritage Portfolio Management Sangamo Therapeutics, Inc Transaction History
Meritage Portfolio Management
- $1.55 Billion
- Q2 2025
A detailed history of Meritage Portfolio Management transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Meritage Portfolio Management holds 127,000 shares of SGMO stock, worth $72,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,000
Previous 92,500
37.3%
Holding current value
$72,390
Previous $61,000
11.48%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SGMO
# of Institutions
140Shares Held
52.4MCall Options Held
2.22MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$5.34 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.92 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.68 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.81 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.3 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $89.2M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...